haematologic cancers

Oncology

Genetic engineering technologies allow for the creation of custom-made cells that can have transformative effects on human health.

News

AI-powered drug discovery company Iambic Therapeutics has announced the terms of its Nasdaq IPO, pitching at a valuation of more than $800m.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.